Skip to main content

Table 1 Baseline demographic and clinical characteristics of E-CS and E-CPR patients

From: Short-term and intermediate outcomes of cardiogenic shock and cardiac arrest patients supported by venoarterial extracorporeal membrane oxygenation

  All E-CS E-CPR
Patients, n (%) 90 (100) 50 (55.6) 40 (44.4)
Age (years), mean (SD) 58.8 (15.8) 60.0 (16.0) 57.4 (15.6)
Gender
 Male, n (%) 64 (71.1) 34 (68.0) 30 (75.0)
 Female, n (%) 26 (28.9) 16 (32.0) 10 (25.0)
BMI, mean (SD) 30.7 (6.96) 29.1 (7.28) 32.9 (5.93)
Race
 White, n (%) 43 (47.8) 24 (48.0) 19 (47.5)
 Black, n (%) 16 (17.8) 9 (18.0) 7 (17.5)
 Asian, n (%) 13 (14.4) 8 (16.0) 5 (12.5)
 Other, n (%) 18 (20.0) 9 (18.0) 9 (22.5)
Transfers, n (%) 40 (44.4) 30 (60.0) 10 (25.0)
Dual MCS therapy (Impella, IABP) 34 (37.8) 25 (50.0) 9 (22.5)
Diabetes, n (%) 33 (36.7) 17 (34.0) 16 (40.0)
Hypertension, n (%) 59 (65.6) 31 (62.0) 28 (70.0)
Hyperlipidemia, n (%) 39 (43.3) 23 (46.0) 16 (40.0)
Congestive heart failure, n (%) 20 (22.2) 14 (28.0) 6 (15.0)
Peripheral vascular disease, n (%) 8 (8.9) 6 (12.0) 2 (5.0)
Coronary artery disease, n (%) 56 (62.2) 31 (62.0) 25 (62.5)
Chronic obstructive pulmonary disease, n (%) 7 (7.8) 4 (8.0) 3 (7.5)
CKD/ESRD, n (%) 12 (13.3) 9 (18.0) 3 (7.5)
Past myocardial infarction, n (%) 21 (23.3) 11 (22.0) 10 (25.0)
Past cerebrovascular accident, n (%) 10 (11.1) 8 (16.0) 2 (5.0)
Smoking, n (%) 22 (24.4) 11 (22.0) 11 (27.5)
Ventilator support, n (%) 69 (76.7) 35 (70.0) 34 (85.0)
AKI/ RF (prior to ECMO initiation), n (%) 12 (13.3) 10 (20.0) 2 (5.0)
  1. AKI acute kidney injury, BMI body mass index, CKD chronic kidney disease, ECMO extracorporeal membrane oxygenation, E-CPR extracorporeal cardiopulmonary resuscitation, E-CS venoarterial extracorporeal membrane oxygenation for cardiogenic shock, ESRD end-stage renal disease, IABP intra-aortic balloon pump, MCS mechanical circulatory support, RF renal failure, SD standard deviation